Axovia Therapeutics
About:
Axovia Therapeutics develops transformative therapies targeting critical aspects of ciliopathies.
Website: https://axoviatherapeutics.com
Top Investors: A Race Against Blindness
Description:
Axovia is dedicated to developing disease-transformative therapies that target key aspects of ciliopathies, addressing the devastating impact of the disease head-on for patients, their families, and caregivers. Axovia Therapeutics is advancing its pipeline to deliver innovative treatments for rare genetic disorders, particularly those leading to blindness.
Total Funding Amount:
$1M
Headquarters Location:
London, England, United Kingdom
Founded Date:
1999-01-01
Founders:
Philip Beales, Victor Hernandez
Number of Employees:
11-50
Last Funding Date:
2024-10-30
IPO Status:
Private
Industries:
© 2025 bioDAO.ai